Safety and Tolerability Evaluation Profile in RMS Patients Starting Rebif New Formulation (STEP)

18/10/2018
01/04/2024
EU PAS number:
EUPAS26126
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information